Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study of Imaging-based Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastomas

NCT04143425 is registered in ClinicalTrials.gov with Ho Sung Kim as lead sponsor.

NCT NCT04143425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04143425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study of Imaging-based Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastomas
Lead sponsor
Ho Sung Kim
Phase
Observational
Overall status
Completed
Start date
February 6, 2020
Completion date
November 1, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult glioblastoma, bevacizimab, magnetic resonance imaging